Percutaneous CT-guided Radiofrequency Ablation for Lymph Node Oligometastases from Hepatocellular Carcinoma: A Propensity Score–matching Analysis
Authors:
- Tao PanTPTao Pan
- Qian-Kun XieQXQian-Kun Xie
- Ning LvNLNing Lv
- Xi-Shan LiXLXi-Shan Li
- Lu-Wen MuLMLu-Wen Mu
- Pei-Hong WuPWPei-Hong Wu
- Ming ZhaoMZMing Zhao
- 1 January 2017
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 282 (1) , 259-270
Abstract
Percutaneous CT-guided radiofrequency ablation may be a safe and effective local-regional therapeutic option for lymph node oligometastases in select patients with hepatocellular carcinoma. Purpose To assess the effectiveness and safety of percutaneous computed tomography (CT)–guided radiofrequency ablation (RFA) for lymph node (LN) oligometastases from hepatocellular carcinoma (HCC). Materials and Methods This retrospective study was approved by the institutional ethics committee, and all patients provided written informed consent. From January 2004 to December 2013, 119 consecutive patients with HCC and LN oligometastases (115 men [mean age, 51.3 years; age range, 16–83 years] and four women [mean age, 38.2 years; age range, 23–47 years]) were included in this study. A matched cohort composed of 46 patients from each group was selected after adjustment with propensity score matching. The median follow-up time was 14.0 months in the RFA group and 13.8 months in the non-RFA group. The overall survival (OS), local control rate, and complications were evaluated. Survival curves were constructed with the Kaplan-Meier method and compared by using the log-rank test. Results Eighty-seven patients ...Keywords
This publication has 27 references indexed in Scilit:
- Positive Lymph Node Metastasis Has a Marked Impact on the Long-Term Survival of Patients with Hepatocellular Carcinoma with Extrahepatic MetastasisPLOS ONE, 2014
- Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasisMolecular and Clinical Oncology, 2014
- Impact of Histologically Confirmed Lymph Node Metastases on Patient Survival After Surgical Resection for Hepatocellular CarcinomaAnnals of Surgery, 2014
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trialJournal of Hepatology, 2012
- CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvementEuropean Journal of Radiology, 2012
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trialEuropean Journal of Cancer, 2012
- Oligometastases revisitedNature Reviews Clinical Oncology, 2011
- Radiotherapy for lymph node metastases in patients with hepatocellular carcinoma: Retrospective studyJournal of Gastroenterology and Hepatology, 2007
- The Role of Lymphadenectomy for Liver TumorsAnnals of Surgery, 2004
- Extrahepatic Metastases of Hepatocellular CarcinomaRadiology, 2000